Greg is an experienced entrepreneur that has served in a number of diverse operating roles throughout his career. Positions have included executive officer roles in two public companies (NYSE and NASDAQ), president of four distinct business groups, and head of business development with significant M&A and corporate finance experience. Prior to NKore, Greg served as CEO of Alafair Biosciences, a commercial stage biomedical company developing a platform of biologic products based on its patented non-cell adhesive hydrogel technology. Prior to Alafair, Greg served as President and CEO of BioD, a biomedical company in the regenerative medicine segment. BioD was sold to a public company in 2016. Previously, he served as President of Diagnostic Health Corporation, then a division of a public company and the fifth largest provider of independent outpatient diagnostic imaging services in the country. The division was sold to a private equity group. Greg also served as President of the Clinical Tomograph Business Group, a $350 million division of CTI Molecular Imaging Inc. CTI was the industry leader in positron emission tomography (PET) and PET/CT technology and was sold to Siemens AG in 2005. Prior to his corporate and entrepreneurial roles, Greg was a corporate finance partner with Alston & Bird LLP in Atlanta, GA. He earned a B.S. degree in Electrical Engineering from the University of Notre Dame; a Juris Doctor from the University of Georgia School of Law; and an MBA from the MIT Sloan School of Management. He also served four years on active duty in the U.S. Army assigned to the 7th Infantry Division at Fort Ord, California.